A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 177
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LRP
Long Form : lung resistance protein
No. Year Title Co-occurring Abbreviation
2020 IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-kappaB Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell. GEM, mTOR, NF-kappaB
2019 Multidrug resistance affects the prognosis of primary epithelial ovarian cancer. GSTP1, MSP, PEOC, RASSF1A, RT-qPCR
2018 Expression of multidrug-resistance associated proteins in human retinoblastoma treated by primary enucleation. GSTpi, ON, P-gp, Rb
2018 Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer. ANCC, CPIR, GSTP1, PEOC
2018 The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma. EMT, HPSE, SRCA
2017 Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells. ---
2017 Differential expression of breast cancer-resistance protein, lung resistance protein, and multidrug resistance protein 1 in retinas of streptozotocin-induced diabetic mice. BCRP, BRB, DR, FITC, MDR1, VEGF-A, ZO-1
2017 Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells. ADM, GST, MDR, MRP1, RES
2017 Expression levels of resistant genes affect cervical cancer prognosis. CC, GSTP1, MDR
10  2017 Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line. DOX, MDR1, MRP1, SML
11  2016 Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression. GA, MRP2
12  2016 Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy. NSCLC, OS, PFS
13  2016 [Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells]. IC50
14  2015 Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid. ABCG2, ANXA1, CSC, EMT, FAK, FPRs, PCa, ZA
15  2015 Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms. 5-FU, HBV, HCC, HIF-1alpha, MMP, P-gp
16  2015 Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study. BCRP, MDR, MDR1, MRP1, SPECT, YB-1
17  2015 Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer. FIGO, MRP, P-gp
18  2015 High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia. MRP, RER, SER
19  2015 [Effect of Peimine on ERCC1 mRNA and LRP Expressions of A549/DDP Multidrug Resistance Cell Line]. ERCC1, MDR
20  2015 [Influence and mechanism of PinX1 gene on the chemotherapy sensitivity of nasopharyngeal carcinoma cells in response to Cisplatin]. PCR, PI
21  2014 Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells. MDR
22  2014 Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome. ABC, ALDH1, ATC, CSC, MRP1, P-gp1, PTC
23  2014 FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia. AML, BCRP, DFS, FLT3-ITD, MLL-PTD, mRNA, MRP-1, RR
24  2014 [Study on the mechanism of reversal effect of Curcuma Wenyujin on MDR of SGC7901/VCR]. ADM, CWNAE, FCM, GCS, IHC, MDR, P-gp
25  2013 Expression of efflux transporters in human ocular tissues. BCRP, HCEC, ICB, MDR1, MRP1-7
26  2013 TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. 5-FU, ERCC1, GST-pi, P-gp, RI, TFPI-2
27  2013 The association of glutathione S-transferase gene mutations (including GSTT1 and GSTM1) with the prognostic factors and relapse in acute lymphoblastic leukemia. ALL, CNS, GST, MRP, WBC
28  2013 [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients]. ---
29  2012 Effect of nitric oxide on the daunorubicin efflux mechanism in K562 cells. NO, RT-PCR, SNAP
30  2012 Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance. MDR
31  2012 The expression and significance of MRP1, LRP, TOPOIIbeta, and BCL2 in tongue squamous cell carcinoma. Bcl-2, MRP1, TopoIIbeta
32  2012 [Proteins of resistance and drug resistance in ovarian carcinoma patients]. MRP
33  2011 Expressions of topoisomerase IIalpha and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. BCRP, MRP1, NSCLC, P-gp, SCLC, TOPIIalpha
34  2011 Lung resistance protein and multidrug resistance protein in non-small cell lung cancer and their clinical significance. MRP, NSCLC
35  2011 Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. ERCC1, GST-pi, MAPK, MDR, RI
36  2010 Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. MDR, NSCLC, PTX
37  2010 Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia. ALL, MDR, MRP1
38  2009 Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. ABCG2, ESCC, GST, MDR1, MRP1
39  2009 Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells. ABC, BCRP, MDR, MRP1, NBL, RMS
40  2009 Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. ---
41  2009 The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer. MRP, P-gp, SP
42  2009 [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma]. MRP, P-gp
43  2008 Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. MDR, P-gp, PGCA, topo II
44  2008 Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. MDR, P-gp, PGCA, topo II
45  2008 Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas. BCRP, MDR, MRP-1
46  2008 Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. MDR, P-gp, Rh123
47  2008 [Correlations of EGFR and LRP to chemotherapy resistance and prognosis of ovarian cancer]. EGFR
48  2007 Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia. AML, HSCT, MRP1, P-gp
49  2007 Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins. BCRP, CsA, MRP-1
50  2007 Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. ALL, BCRP, MDR, MDR1, MRP1
51  2007 MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy. MDR, mRNA, MRP1
52  2007 TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes? MDR, mRNA, P-gp, Tc-99m MIBI, WR
53  2007 The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. AML, CR, EFS, MDR, MRP, OS, P-gp
54  2007 The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance. ADM, BCRP, HCC, MDR, MDR1, MRP1
55  2007 [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer]. MRP1, P-gp
56  2007 [Expressions of LRP, GST-pi and MRP1 in acute leukemia patients and its clinical significance]. AL, GST-pi, MRP-1
57  2007 [Relationship between expression of apoptosis-related genes and multidrug resistance genes in lung cancer tissues and their clinical significance]. GST-pi, MDR, MRP, P-gp, topo II
58  2006 Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma. CCOC, GST, MRP, P-gp, PSOC
59  2006 Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins. MDR, MRP
60  2006 Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes. MDR1, MDS, OL, OL
61  2006 IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes. IAP, MDR, MM
62  2006 Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas. MDR, MRP1, P-gp
63  2006 Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. MDR, MDR1, MRP
64  2006 Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia. ALL, BCRP, MDR, MRP1, P-gp
65  2006 The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines. MDR, P-gp
66  2006 [Study on the relationship among multidrug resistance factor expression of lung cancer tissues and clinicopathological characteristics in patients with lung cancer]. GST-pi, MDR, MRP, P-gp, topo II
67  2006 [The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues]. MRP, P-gp, RFI
68  2005 Cyclosporin A is a broad-spectrum multidrug resistance modulator. AML, BCRP, P-gp
69  2005 Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma. DLBCL, MDR, MRP1, P-gp
70  2005 MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. AML, FLT3, MDR
71  2005 Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. MRP1, NSCLC, P-gp, RT-PCR
72  2005 The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group. ALL, MDR, MRP1, P-gp
73  2005 [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance]. ALL, ANLL, CR, MRP, RT-PCR
74  2005 [Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell]. HIF-1alpha
75  2005 [The effect of tetrandrine on the expression of the P170, LRP and TOPO II in S180's tumor cell induced by chemotherapy in the mice with acquired multi-drug resistance]. ---
76  2004 CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. AML, BM, MDR, MRP, P-gp
77  2004 Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma. MIBI, mRNA, MRP, P-gp
78  2004 Expression of multidrug resistance-related markers in primary neuroblastoma. MRP, P-gp, SP
79  2004 Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia. AML, BCRP, CBF, MDR, MRP-1, P-gp
80  2004 Heterogeneity in the expression of markers for drug resistance in brain tumors. MGMT, P-gp
81  2004 Highly refractory acute myeloid leukemia. AML, CR, P-gp
82  2004 In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. 2-CdA, ALL, HOO, L-ASP, PRED
83  2004 Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. MDR
84  2004 Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. CALLA, MRP, RT-PCR
85  2004 [Coexpression and clinical significance of multi-drug resistance factors in lung cancer]. MRP, P-gp
86  2004 [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III]. MDR, MRP, NSCLC, P-gp
87  2004 [The effect of matrine on the expression of P170 LRP and TOPO II of obtained multi-drug resistance of mouse S180's tumour cell]. ---
88  2003 C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective. CHOP, CLL, COP, GP, GST-Pi, MRP
89  2003 Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins. P-gp
90  2003 Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates. CO, DC, GM-CSF, IL-4, P-gp, SDS
91  2003 Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML. AML, CyA, DNR, MI, MRP, P-gp, RT-PCR
92  2003 Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines. hTERT, MDR, MRP, RT-PCR, topo IIalpha
93  2003 Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin. MRP, MT, P-gp, SPA
94  2003 Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. P-gp
95  2003 LRP overexpression in monocytic lineage. AML, ICC
96  2003 Multidrug resistance in hematological malignancy. ARA, BCRP, MRP, P-Gp, TAP
97  2003 Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. AEDs, CNS, EC
98  2003 [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma]. GST-pi, MDR, MRP, topo IIalpha
99  2003 [Expression of lung resistance protein and multidrug resistance protein genes in bone marrow cells of acute leukemia patients and its clinical significance]. CR, MRP, RT-PCR
100  2003 [Expression of P-glycoprotein and lung resistance protein in breast carcinoma and its relationship with prognosis]. P-gp